CClinicalTrials.gg
CompletedNCT03043378Updated Mar 28, 2023

Chronic Non-Malignant Pain in Cancer Patients at a Supportive Care Clinic

An observational study in Malignant Neoplasms of Independent (Primary) Multiple Sites, sponsored by M.D. Anderson Cancer Center. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-03-28.

Sponsored by M.D. Anderson Cancer Center · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
201
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this research study is to learn how frequently cancer patients in the Supportive Care Center have chronic, non-malignant pain. Chronic, non-malignant pain is pain that is neither related to cancer nor its treatment and lasts beyond the normal tissue healing time of 3 months.

Read the detailed description

If participant is found to be eligible and agrees to take part in this study, participant will be asked to complete 3 questionnaires about participant's pain, pain level, and what drugs participant takes to treat participant's pain. Participant will also be asked a few questions about tobacco use. These questionnaires should take about 20 minutes to complete.

Researchers will also collect information from participant's medical record such as participant's date of birth, sex, race, marital status, economic background, and medical history.

Length of Study:

Participation on this study will be over after participant has completed the last questionnaire.

This is an investigational study.

Up to 200 participants will be enrolled in this study. All will take part at MD Anderson.

02

Conditions studied

  • Malignant Neoplasms of Independent (Primary) Multiple Sites

Browse trials for

Keywords

  • Malignant Neoplasms of Independent (Primary) Multiple Sites
  • Non-malignant pain
  • Supportive care
  • Questionnaires
  • Surveys
  • Chronic non-malignant pain
03

In context

Neoplasms

9,365 studies on the registry are indexed under Neoplasms; 2,489 are open to participants now.

This study's enrollment of 201 is close to the median of 204 across 1,683 observational studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

M.D. Anderson Cancer Center is the lead sponsor of 2,999 studies on the registry; 581 are open to participants now.

Of its 599 completed or terminated interventional studies of FDA-regulated products, 402 (67%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Participants undergoing consultation at the Supportive Care Clinic at MD Anderson Cancer Center.

Inclusion criteria

  1. Diagnosis of cancer with or without active disease
  2. Consultation visit at an outpatient supportive care clinic
  3. Age 18 or greater
  4. Report of having pain within the last 3 months

Exclusion criteria

Exclusion Criteria:

  1. Memorial Delirium Assessment Scale >13
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
201 participants (actual)
Patient registry
No

Groups and cohorts

  • Chronic Non-Malignant Pain - Cancer Patients

    Chronic non-malignant pain among cancer patients undergoing a consultation at the outpatient Supportive Care Clinic at MD Anderson Cancer Center.

    Behavioral: Questionnaires

Interventions

  • BehavioralQuestionnaires

    Participants complete three questionnaires at consultation visit.

    Also known as: Surveys

06

What researchers measure

Primary outcomes

  1. Frequency of Chronic Non-Malignant Pain Among Cancer Patients

    Frequency assessed by Edmonton Symptom Assessment Scale (ESAS-FS)

    Time frame: 1 day

  2. Frequency of Chronic Non-Malignant Pain Among Cancer Patients

    Frequency assessed by Brief Pain Inventory.

    Time frame: 1 day

  3. Frequency of Chronic Non-Malignant Pain Among Cancer Patients

    Frequency assessed by the Charlson Comorbidity Index.

    Time frame: 1 day

  4. Frequency of Chronic Non-Malignant Pain Among Cancer Patients

    Frequency assessed by Pain Characteristic Survey.

    Time frame: 1 days

  5. Frequency of Chronic Non-Malignant Pain Among Cancer Patients

    Frequency assessed by Karnofsky Performance Scale.

    Time frame: 1 day

07

Study locations

1 site
  • University of Texas MD Anderson Cancer Center
    Houston, Texas 77030, United States
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 28, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03043378
Lead sponsor
M.D. Anderson Cancer Center
Responsible party
Sponsor
First posted
Feb 6, 2017
Start date
Jul 31, 2018
Primary completion
Mar 23, 2023
Completion
Mar 23, 2023
Last update
Mar 28, 2023

Study contacts

David Hui, MD
principal investigator · M.D. Anderson Cancer Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion